Your one-stop web resource providing safety and security information to manufacturers

Israeli startup Medigate launched today with a goal to secure the use of the millions of connected medical devices on healthcare provider networks.

Backing for the technology platform, which lets CISOs and security teams defend networked medical devices from cyberattacks, comes from YL Ventures, with additional funding from Blumberg Capital. Medigate received $5.35 million in seed funding.

Kaspersky Lab’s Threat Hunting Services
Securing Industrial Control, IoT Devices
Rockwell Automation Invests in AI
IT-OT Network Monitoring Pact

Healthcare providers depend on nearly 100 million connected medical devices to deliver cost-effective and lifesaving treatment to patients, and the number of these connected devices is expected to double in the next 2-3 years.

Add on top of that, cyberattacks targeting healthcare providers is also skyrocketing. Over 90 percent of healthcare providers suffered at least one data breach in the last two years, according to research by the Ponemon Institute.

Cyber Security

Medical devices are already a target, as seen in attacks such as MEDJACK that started in 2015 and continues today. Existing and pending patient privacy and medical device regulations and FDA guidance raise the stakes even more.

IT and security operations teams must do more to protect their organizations and their patients. That is where Medigate comes in.

Medigate offers a dedicated platform for securing networked medical devices connected to electronic medical records, device servers, other enterprise systems and the Internet.

Medigate’s solution fuses the knowledge and understanding of medical workflow and device identity and protocols with the reality of today’s cybersecurity threats. Medigate offers visibility into all the medical devices connected to the network, fully identify these devices by type and personality and analyze and understand their specialized protocols, communications and behaviors. By using this knowledge to detect anomalies and suspicious activities, Medigate protects connected medical devices from network attacks and data exfiltration attempts.

“Connected medical devices – from patient monitors, MRIs and CAT scanners to infusion pumps and yet-to-be invented devices — are critical to the delivery of healthcare today and are revolutionizing the care of tomorrow,” said Yoav Leitersdorf, managing partner at YL Ventures, which led the Medigate funding round. “These devices are inherently different from traditional IT endpoints and can’t be protected by currently available products and practices. With the pandemic of cyberattacks targeting healthcare providers, far too many connected devices are left vulnerable and exposed, putting patient health and privacy at risk. Medigate’s solution directly addresses this crucial problem by mitigating targeted attacks on medical devices.”

To be competitive in care delivery and cost, today’s medical providers must be able to quickly and safely connect existing and new devices to their networks, said Jonathan Langer, Medigate chief executive and co-founder.

“It’s an imperative to connect devices to the network, both to manage and monitor devices in real time and to understand and analyze the large amounts of data generated from these devices. At the same time, we see backdoor attacks like MEDJACK and ransomware attacks like WannaCry and NotPetya successfully targeting healthcare providers. Connected devices are a ripe target for cybercriminals,” Langer said. “The Medigate solution is designed to effectively protect medical devices from these attacks and eliminate this pandemic risk.”

Click here to visit the Medigate web site.

Pin It on Pinterest

Share This